Mgo One Seven LLC Crispr Therapeutics Ag Transaction History

Mgo One Seven LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$110.2 - $156.64 $213,347 - $303,255	-1,936 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$100.84 - $161.89 $49,814 - $79,973	-494 Reduced 20.33%	1,936 $313,000
Q1 2021 Apr 29, 2021	BUY	$110.72 - $210.04 $38,752 - $73,514	350 Added 16.83%	2,430 $296,000
Q4 2020 Jan 22, 2021	BUY	$79.67 - $173.23 $165,713 - $360,318	2,080 New	2,080 $318,000
Q1 2019 Apr 09, 2019	SELL	$28.02 - $40.87 $56,040 - $81,740	-2,000 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$22.73 - $42.34 $45,460 - $84,680	2,000 New	2,000 $57,000
Q3 2018 Oct 09, 2018	SELL	$44.35 - $65.71 $88,700 - $131,420	-2,000 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$16.95 - $23.48 $33,900 - $46,960	2,000	2,000 $47,000

488

64.1M

1.64M

1.93M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.28B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.